| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| RBC Capital Markets | 10,00$ | -26,09% | 17.04.12 | |||
| UBS AG | 8,00$ | -40,87% | 12.04.12 | |||
| Barclays Capital | 9,00$ | -33,48% | 29.02.12 | |||
| Piper Jaffray & Co. | 11,00$ | -18,70% | 23.02.12 | |||
| Citigroup Corp. | 12,00$ | -11,31% | 27.10.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Amgen Inc. | 5 | 10 | 1 | 72,09 $ | +6,41% |
| Celgene Corp. | 8 | 1 | 0 | 82,71 $ | +26,60% |
| GlaxoSmithKline plc (GSK) | 5 | 8 | 1 | 15,31 £ | +8,20% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +3,55% |
| Novartis AG | 10 | 8 | 1 | 56,60 | +13,27% |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 5 | 2 | 0 | 54,33 $ | +39,27% |